Boston Trust Walden’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.1M Sell
307,828
-10,445
-3% -$2.56M 0.56% 56
2025
Q4
$80.7M Sell
318,273
-5,991
-2% -$1.5M 0.61% 48
2025
Q3
$80.2M Buy
324,264
+284
+0.1% +$68K 0.59% 48
2025
Q2
$77.8M Buy
323,980
+67,709
+26% +$15.8M 0.56% 59
2025
Q1
$58.1M Buy
256,271
+31,530
+14% +$6.93M 0.42% 86
2024
Q4
$46.2M Buy
224,741
+179,829
+400% +$39.5M 0.32% 124
2024
Q3
$10.9M Buy
44,912
+118
+0.3% +$27.6K 0.08% 201
2024
Q2
$9.83M Buy
44,794
+880
+2% +$191K 0.07% 199
2024
Q1
$9.87M Sell
43,914
-666
-1% -$150K 0.07% 196
2023
Q4
$9.8M Sell
44,580
-121,561
-73% -$25.7M 0.07% 194
2023
Q3
$36.5M Sell
166,141
-65,705
-28% -$14.9M 0.31% 118
2023
Q2
$52.2M Sell
231,846
-11,776
-5% -$2.36M 0.43% 83
2023
Q1
$46.6M Buy
243,622
+7,479
+3% +$1.45M 0.4% 88
2022
Q4
$43.6M Buy
236,143
+1,284
+0.5% +$226K 0.38% 90
2022
Q3
$39.1M Sell
234,859
-1,032
-0.4% -$210K 0.39% 93
2022
Q2
$48.6M Buy
235,891
+2,521
+1% +$568K 0.46% 74
2022
Q1
$56.4M Buy
233,370
+5,542
+2% +$1.28M 0.47% 74
2021
Q4
$55.5M Buy
227,828
+811
+0.4% +$185K 0.45% 72
2021
Q3
$46.4M Buy
227,017
+14,326
+7% +$3.07M 0.41% 86
2021
Q2
$43.9M Buy
212,691
+14,144
+7% +$2.85M 0.39% 91
2021
Q1
$37.8M Buy
198,547
+22,160
+13% +$4.11M 0.37% 99
2020
Q4
$33.4M Buy
176,387
+3,407
+2% +$636K 0.36% 93
2020
Q3
$30.5M Buy
172,980
+1,911
+1% +$306K 0.38% 80
2020
Q2
$26.2M Buy
171,069
+4,393
+3% +$669K 0.35% 87
2020
Q1
$23.3M Buy
166,676
+5,015
+3% +$750K 0.37% 80
2019
Q4
$24.6M Buy
161,661
+21,422
+15% +$3.14M 0.29% 105
2019
Q3
$20.3M Buy
140,239
+10,146
+8% +$1.52M 0.25% 119
2019
Q2
$19.4M Buy
130,093
+595
+0.5% +$79.5K 0.25% 119
2019
Q1
$16.6M Buy
129,498
+4,628
+4% +$545K 0.23% 133
2018
Q4
$13.3M Buy
124,870
+12,250
+11% +$1.37M 0.21% 135
2018
Q3
$12.9M Sell
112,620
-9,705
-8% -$1.1M 0.18% 156
2018
Q2
$12.8M Buy
122,325
+6,390
+6% +$643K 0.19% 154
2018
Q1
$10.8M Buy
115,935
+1,024
+0.9% +$93.1K 0.16% 174
2017
Q4
$10.1M Buy
114,911
+4,667
+4% +$416K 0.15% 185
2017
Q3
$9.75M Buy
110,244
+1,439
+1% +$122K 0.15% 184
2017
Q2
$8.87M Buy
108,805
+15,006
+16% +$1.14M 0.14% 178
2017
Q1
$6.51M Buy
93,799
+2,436
+3% +$169K 0.1% 210
2016
Q4
$6.16M Buy
91,363
+5,200
+6% +$353K 0.1% 209
2016
Q3
$6.3M Buy
86,163
+284
+0.3% +$20.1K 0.1% 204
2016
Q2
$5.91M Sell
85,879
-696
-0.8% -$48.8K 0.1% 209
2016
Q1
$6.15M Buy
+86,575
New +$5.86M 0.11% 206
2015
Q4
Sell
-660,700
Closed -$42.9M 355
2015
Q3
$42.9M Sell
660,700
-21,370
-3% -$1.41M 0.72% 34
2015
Q2
$44M Sell
682,070
-7,367
-1% -$497K 0.67% 38
2015
Q1
$48.4M Buy
689,437
+6,718
+1% +$443K 0.72% 34
2014
Q4
$44.3M Buy
+682,719
New +$42.2M 0.66% 48

Other funds holding STE

Boston Trust Walden's STE Position: Q1 2026 in Review

Boston Trust Walden reduced its Steris (STE) stake by 3.3% in Q1 2026, selling an estimated $2.56M and leaving 307,828 shares worth $68.1M. The position accounts for 0.56% of the portfolio, ranked #56.

Boston Trust Walden first reported a position in STE in Q4 2014 and has held it in 45 quarters since. The position peaked at $80.7M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Boston Trust Walden held 307,828 shares of Steris worth $68.1M as of Q1 2026.
  • Boston Trust Walden sold 10,445 Steris shares in Q1 2026, an estimated $2.56M.
  • Steris made up 0.56% of Boston Trust Walden's portfolio in Q1 2026, its #56 holding.
  • Boston Trust Walden first reported a position in Steris in Q4 2014 and has held it in 45 quarters since.
  • Boston Trust Walden's Steris position peaked at $80.7M in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.